

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.77537936 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.77537936 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.44188701 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.31841125 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.93487420 |
| 6 | modulation by virus of host process (GO:0019054) | 4.82777211 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.39819560 |
| 8 | regulation of chromatin binding (GO:0035561) | 4.28174563 |
| 9 | modulation by symbiont of host cellular process (GO:0044068) | 4.14082851 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.06730937 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.02731568 |
| 12 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.99076202 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 3.86853814 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 3.84614845 |
| 15 | chromosome condensation (GO:0030261) | 3.83139040 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 3.79114625 |
| 17 | DNA packaging (GO:0006323) | 3.57077369 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53755999 |
| 19 | regulation of B cell differentiation (GO:0045577) | 3.48611181 |
| 20 | positive regulation of histone deacetylation (GO:0031065) | 3.48446029 |
| 21 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.41080300 |
| 22 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.34886898 |
| 23 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.32049226 |
| 24 | thymic T cell selection (GO:0045061) | 3.26440975 |
| 25 | negative T cell selection (GO:0043383) | 3.22683318 |
| 26 | T cell selection (GO:0045058) | 3.18800297 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.17153716 |
| 28 | pentose-phosphate shunt (GO:0006098) | 3.16779006 |
| 29 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.11588858 |
| 30 | negative regulation of phagocytosis (GO:0050765) | 3.10315668 |
| 31 | activation of Rac GTPase activity (GO:0032863) | 3.08481699 |
| 32 | histone H3-K36 demethylation (GO:0070544) | 3.08250461 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.08173430 |
| 34 | leukocyte aggregation (GO:0070486) | 3.08066052 |
| 35 | positive T cell selection (GO:0043368) | 3.05284729 |
| 36 | apoptotic process involved in morphogenesis (GO:0060561) | 3.01880375 |
| 37 | natural killer cell differentiation (GO:0001779) | 3.01666703 |
| 38 | response to peptidoglycan (GO:0032494) | 2.98848852 |
| 39 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.96870196 |
| 40 | positive regulation of protein deacetylation (GO:0090312) | 2.96149267 |
| 41 | G1 DNA damage checkpoint (GO:0044783) | 2.94524026 |
| 42 | snRNA metabolic process (GO:0016073) | 2.92047089 |
| 43 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.90687032 |
| 44 | regulation of RNA export from nucleus (GO:0046831) | 2.90420196 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 2.89462660 |
| 46 | nuclear pore organization (GO:0006999) | 2.89205992 |
| 47 | response to muramyl dipeptide (GO:0032495) | 2.88239854 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.87905169 |
| 49 | mitotic G1/S transition checkpoint (GO:0044819) | 2.87018144 |
| 50 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.86438519 |
| 51 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.82926902 |
| 52 | negative regulation of stress fiber assembly (GO:0051497) | 2.81039722 |
| 53 | nuclear pore complex assembly (GO:0051292) | 2.80289593 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 2.79699708 |
| 55 | dosage compensation (GO:0007549) | 2.79507381 |
| 56 | mannose metabolic process (GO:0006013) | 2.78520908 |
| 57 | GDP-mannose metabolic process (GO:0019673) | 2.75988478 |
| 58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75734581 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73592503 |
| 60 | lymph vessel development (GO:0001945) | 2.72791736 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.72421146 |
| 62 | chromatin silencing (GO:0006342) | 2.72265473 |
| 63 | NADPH regeneration (GO:0006740) | 2.71124882 |
| 64 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.69501528 |
| 65 | cellular hyperosmotic response (GO:0071474) | 2.69050854 |
| 66 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67810232 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67465399 |
| 68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67465399 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67465399 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 2.67465399 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67465399 |
| 72 | modulation by symbiont of host defense response (GO:0052031) | 2.67465399 |
| 73 | regulation of ARF GTPase activity (GO:0032312) | 2.65059977 |
| 74 | embryonic process involved in female pregnancy (GO:0060136) | 2.64458065 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64269937 |
| 76 | histone H3-K4 trimethylation (GO:0080182) | 2.63151471 |
| 77 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.62963454 |
| 78 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.61931682 |
| 79 | regulation of histone H3-K9 methylation (GO:0051570) | 2.60026523 |
| 80 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.59426171 |
| 81 | histone H3-K4 methylation (GO:0051568) | 2.58625855 |
| 82 | trophectodermal cell differentiation (GO:0001829) | 2.57114975 |
| 83 | histone H3-K9 modification (GO:0061647) | 2.56899810 |
| 84 | negative regulation of histone methylation (GO:0031061) | 2.56834369 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56818184 |
| 86 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.55995277 |
| 87 | histone lysine demethylation (GO:0070076) | 2.55788193 |
| 88 | histone demethylation (GO:0016577) | 2.54266316 |
| 89 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.53685145 |
| 90 | * negative regulation of viral release from host cell (GO:1902187) | 2.51899501 |
| 91 | cellular response to virus (GO:0098586) | 2.51786401 |
| 92 | regulation of histone H3-K4 methylation (GO:0051569) | 2.51728377 |
| 93 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.48810546 |
| 94 | type I interferon signaling pathway (GO:0060337) | 2.48613904 |
| 95 | cellular response to type I interferon (GO:0071357) | 2.48613904 |
| 96 | atrioventricular valve morphogenesis (GO:0003181) | 2.47854699 |
| 97 | regulation of superoxide anion generation (GO:0032928) | 2.47803439 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47437864 |
| 99 | negative regulation of cell killing (GO:0031342) | 2.47437864 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46392514 |
| 101 | response to interleukin-15 (GO:0070672) | 2.45724368 |
| 102 | positive regulation of lamellipodium assembly (GO:0010592) | 2.45607584 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.45056503 |
| 104 | histone H3-K9 demethylation (GO:0033169) | 2.43706325 |
| 105 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.43067023 |
| 106 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.43067023 |
| 107 | positive regulation of protein homooligomerization (GO:0032464) | 2.42396190 |
| 108 | regulation of integrin activation (GO:0033623) | 2.41261482 |
| 109 | negative regulation of cell size (GO:0045792) | 2.41122708 |
| 110 | T cell lineage commitment (GO:0002360) | 2.40608267 |
| 111 | modulation by virus of host morphology or physiology (GO:0019048) | 2.40121910 |
| 112 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.40067216 |
| 113 | T cell homeostasis (GO:0043029) | 2.39210431 |
| 114 | hepatocyte apoptotic process (GO:0097284) | 2.39189104 |
| 115 | pinocytosis (GO:0006907) | 2.39105832 |
| 116 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.38784004 |
| 117 | morphogenesis of an endothelium (GO:0003159) | 2.38721598 |
| 118 | endothelial tube morphogenesis (GO:0061154) | 2.38721598 |
| 119 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.37151951 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 2.34863228 |
| 121 | V(D)J recombination (GO:0033151) | 2.31934790 |
| 122 | mitotic chromosome condensation (GO:0007076) | 2.31571408 |
| 123 | alpha-linolenic acid metabolic process (GO:0036109) | 2.30916569 |
| 124 | histone H3-K9 methylation (GO:0051567) | 2.30523453 |
| 125 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.29509619 |
| 126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.27690860 |
| 127 | regulation of histone methylation (GO:0031060) | 2.27288900 |
| 128 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.27270266 |
| 129 | Peyers patch development (GO:0048541) | 2.27174924 |
| 130 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.27174924 |
| 131 | protein demethylation (GO:0006482) | 2.26886509 |
| 132 | protein dealkylation (GO:0008214) | 2.26886509 |
| 133 | defense response to fungus (GO:0050832) | 2.26008787 |
| 134 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.25851158 |
| 135 | T cell apoptotic process (GO:0070231) | 2.25712761 |
| 136 | regulation of necroptotic process (GO:0060544) | 2.24691439 |
| 137 | lymphocyte homeostasis (GO:0002260) | 2.24666329 |
| 138 | regulation of histone H3-K27 methylation (GO:0061085) | 2.24096686 |
| 139 | response to laminar fluid shear stress (GO:0034616) | 2.21925411 |
| 140 | negative regulation of granulocyte differentiation (GO:0030853) | 2.21468065 |
| 141 | negative regulation of innate immune response (GO:0045824) | 2.21456797 |
| 142 | regulation of response to interferon-gamma (GO:0060330) | 2.19866730 |
| 143 | T cell receptor signaling pathway (GO:0050852) | 2.19437831 |
| 144 | B cell mediated immunity (GO:0019724) | 2.19064443 |
| 145 | positive regulation of interferon-alpha production (GO:0032727) | 2.18952135 |
| 146 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.18359462 |
| 147 | positive regulation of lamellipodium organization (GO:1902745) | 2.18310061 |
| 148 | RNA stabilization (GO:0043489) | 2.17348685 |
| 149 | mRNA stabilization (GO:0048255) | 2.17348685 |
| 150 | T cell costimulation (GO:0031295) | 2.16550630 |
| 151 | regulation of translational fidelity (GO:0006450) | 2.15914661 |
| 152 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.14279880 |
| 153 | regulation of monocyte differentiation (GO:0045655) | 2.13156126 |
| 154 | negative regulation of necroptotic process (GO:0060546) | 2.11579440 |
| 155 | valine metabolic process (GO:0006573) | 2.11035514 |
| 156 | lymphocyte costimulation (GO:0031294) | 2.09797753 |
| 157 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.09460842 |
| 158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.08961172 |
| 159 | cellular response to zinc ion (GO:0071294) | 2.08842464 |
| 160 | response to type I interferon (GO:0034340) | 2.08540335 |
| 161 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.06644587 |
| 162 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.06441870 |
| 163 | protein-DNA complex disassembly (GO:0032986) | 2.06374274 |
| 164 | nucleosome disassembly (GO:0006337) | 2.06374274 |
| 165 | regulation of granulocyte differentiation (GO:0030852) | 2.06079982 |
| 166 | DNA unwinding involved in DNA replication (GO:0006268) | 2.05890678 |
| 167 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.03902118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.69635971 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.66186288 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99135914 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.96437714 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86780379 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.50270135 |
| 7 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.43653411 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.41108556 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40627611 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.33434138 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.23260208 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.22926664 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22505449 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22050166 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15038926 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08320411 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.07447992 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.03541277 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96739588 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 1.95690860 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94327519 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.94131936 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94126171 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92428706 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92078023 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92007744 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 1.84407609 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82370780 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82171874 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82014166 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78605771 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77062508 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75595923 |
| 34 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75113661 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73372426 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73039476 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70727468 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69993470 |
| 39 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.68391620 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68163876 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67985788 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.66008745 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63801521 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63772948 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61049857 |
| 46 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60063693 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.59943861 |
| 48 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54756499 |
| 49 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.54406957 |
| 50 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54350382 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52983706 |
| 52 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51614040 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.51545124 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51486740 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.50060824 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47792770 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47244951 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47078034 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.46560821 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46548272 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44238033 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44106293 |
| 63 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43775809 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43175477 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42233486 |
| 66 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.35059311 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.32616149 |
| 68 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32238348 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31976920 |
| 70 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.31007808 |
| 71 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.30822250 |
| 72 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.29660089 |
| 73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.27754606 |
| 74 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.27306900 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25832329 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25114430 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25090405 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24927933 |
| 79 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24898634 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24416192 |
| 81 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23645453 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23136116 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22519329 |
| 84 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21098019 |
| 85 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.20905393 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20854062 |
| 87 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.20509381 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19688944 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18098145 |
| 90 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18015586 |
| 91 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17763237 |
| 92 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16711620 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16077529 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15610262 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15014771 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14348555 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14339389 |
| 98 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12245470 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10945812 |
| 100 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10806843 |
| 101 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10703230 |
| 102 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.10420510 |
| 103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09276332 |
| 104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08636034 |
| 105 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.07301606 |
| 106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06679881 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06091756 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05982918 |
| 109 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05872251 |
| 110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.05221609 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04505954 |
| 112 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04310046 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04141604 |
| 114 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04002798 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02922856 |
| 116 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02569908 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01418864 |
| 118 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01377467 |
| 119 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00851902 |
| 120 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00746362 |
| 121 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00409790 |
| 122 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00342460 |
| 123 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00264557 |
| 124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00030358 |
| 125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99903593 |
| 126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99025246 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98290991 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98260378 |
| 129 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97576334 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96486929 |
| 131 | P68_20966046_ChIP-Seq_HELA_Human | 0.94991104 |
| 132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93944598 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92862482 |
| 134 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92518495 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92407633 |
| 136 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92099545 |
| 137 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91435077 |
| 138 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90693836 |
| 139 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.90242746 |
| 140 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89426262 |
| 141 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88343031 |
| 142 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88019205 |
| 143 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87808716 |
| 144 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87148820 |
| 145 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87111862 |
| 146 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.86965312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 2.91999204 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.86009709 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.59521718 |
| 4 | MP0000678_abnormal_parathyroid_gland | 2.51511997 |
| 5 | MP0001800_abnormal_humoral_immune | 2.49054086 |
| 6 | MP0008260_abnormal_autophagy | 2.38433666 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.34682333 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.33626622 |
| 9 | MP0003436_decreased_susceptibility_to | 2.29554744 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.26945934 |
| 11 | MP0005410_abnormal_fertilization | 2.23221627 |
| 12 | MP0005671_abnormal_response_to | 2.11626259 |
| 13 | MP0002249_abnormal_larynx_morphology | 2.11567128 |
| 14 | MP0005387_immune_system_phenotype | 2.10011692 |
| 15 | MP0001790_abnormal_immune_system | 2.10011692 |
| 16 | MP0002398_abnormal_bone_marrow | 2.03272480 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.02487373 |
| 18 | MP0002452_abnormal_antigen_presenting | 1.99231822 |
| 19 | MP0003303_peritoneal_inflammation | 1.97877081 |
| 20 | MP0001348_abnormal_lacrimal_gland | 1.94923019 |
| 21 | MP0009840_abnormal_foam_cell | 1.92490019 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.89355108 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.87333673 |
| 24 | MP0004808_abnormal_hematopoietic_stem | 1.85378614 |
| 25 | MP0001819_abnormal_immune_cell | 1.84778077 |
| 26 | MP0009278_abnormal_bone_marrow | 1.84615865 |
| 27 | MP0000689_abnormal_spleen_morphology | 1.84479333 |
| 28 | MP0002723_abnormal_immune_serum | 1.84123113 |
| 29 | MP0001873_stomach_inflammation | 1.79689221 |
| 30 | MP0000716_abnormal_immune_system | 1.77939501 |
| 31 | MP0002722_abnormal_immune_system | 1.73696025 |
| 32 | MP0004947_skin_inflammation | 1.72382862 |
| 33 | MP0005360_urolithiasis | 1.70190889 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.67745072 |
| 35 | MP0005025_abnormal_response_to | 1.67042563 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.66550049 |
| 37 | MP0002006_tumorigenesis | 1.65404195 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.64697635 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.64697635 |
| 40 | MP0004381_abnormal_hair_follicle | 1.64168627 |
| 41 | MP0009785_altered_susceptibility_to | 1.63468821 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.58480219 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.56775930 |
| 44 | MP0002405_respiratory_system_inflammati | 1.55947691 |
| 45 | MP0002429_abnormal_blood_cell | 1.54617272 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.54010117 |
| 47 | MP0005310_abnormal_salivary_gland | 1.53792191 |
| 48 | MP0001853_heart_inflammation | 1.48755089 |
| 49 | MP0002419_abnormal_innate_immunity | 1.47182890 |
| 50 | MP0005365_abnormal_bile_salt | 1.44387709 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.43440658 |
| 52 | MP0005023_abnormal_wound_healing | 1.39897790 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.35652871 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.34823438 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.30935427 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.30308121 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.29686760 |
| 58 | MP0001346_abnormal_lacrimal_gland | 1.29404498 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.28081130 |
| 60 | MP0000490_abnormal_crypts_of | 1.25372493 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.21682125 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.21250831 |
| 63 | MP0002098_abnormal_vibrissa_morphology | 1.20035263 |
| 64 | MP0000003_abnormal_adipose_tissue | 1.19852470 |
| 65 | MP0000609_abnormal_liver_physiology | 1.18693660 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.18160231 |
| 67 | MP0006054_spinal_hemorrhage | 1.17662809 |
| 68 | MP0003693_abnormal_embryo_hatching | 1.17354371 |
| 69 | MP0010307_abnormal_tumor_latency | 1.15849679 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.15535540 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.14297193 |
| 72 | MP0002933_joint_inflammation | 1.11808200 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.11355494 |
| 74 | MP0000858_altered_metastatic_potential | 1.08663969 |
| 75 | MP0000313_abnormal_cell_death | 1.08531571 |
| 76 | MP0003786_premature_aging | 1.07846559 |
| 77 | MP0003077_abnormal_cell_cycle | 1.06012259 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.05992931 |
| 79 | MP0010329_abnormal_lipoprotein_level | 1.02846084 |
| 80 | MP0004957_abnormal_blastocyst_morpholog | 1.01651018 |
| 81 | MP0005501_abnormal_skin_physiology | 1.00350780 |
| 82 | MP0001849_ear_inflammation | 0.99865478 |
| 83 | MP0008469_abnormal_protein_level | 0.98935671 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.98708294 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.98042343 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 0.97855663 |
| 87 | MP0002796_impaired_skin_barrier | 0.97367794 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.96395278 |
| 89 | MP0009931_abnormal_skin_appearance | 0.95427563 |
| 90 | MP0003878_abnormal_ear_physiology | 0.94878193 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 0.94878193 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.94852189 |
| 93 | MP0000681_abnormal_thyroid_gland | 0.93956432 |
| 94 | MP0003111_abnormal_nucleus_morphology | 0.93289468 |
| 95 | MP0003252_abnormal_bile_duct | 0.92853302 |
| 96 | MP0002254_reproductive_system_inflammat | 0.91346033 |
| 97 | MP0000598_abnormal_liver_morphology | 0.90768523 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.90184210 |
| 99 | MP0002132_abnormal_respiratory_system | 0.90127467 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.89530465 |
| 101 | MP0003866_abnormal_defecation | 0.87966100 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.85808718 |
| 103 | MP0001929_abnormal_gametogenesis | 0.84392127 |
| 104 | MP0001243_abnormal_dermal_layer | 0.83932160 |
| 105 | MP0002060_abnormal_skin_morphology | 0.83509802 |
| 106 | MP0001533_abnormal_skeleton_physiology | 0.83299617 |
| 107 | MP0003698_abnormal_male_reproductive | 0.83230121 |
| 108 | MP0004858_abnormal_nervous_system | 0.82732329 |
| 109 | MP0006082_CNS_inflammation | 0.81757278 |
| 110 | MP0009763_increased_sensitivity_to | 0.81174482 |
| 111 | MP0001216_abnormal_epidermal_layer | 0.80956173 |
| 112 | MP0002009_preneoplasia | 0.80783036 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.80372626 |
| 114 | MP0003091_abnormal_cell_migration | 0.80162346 |
| 115 | MP0008057_abnormal_DNA_replication | 0.79881481 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.79781679 |
| 117 | MP0003279_aneurysm | 0.78890048 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.75709677 |
| 119 | MP0004510_myositis | 0.75507182 |
| 120 | MP0005621_abnormal_cell_physiology | 0.75459778 |
| 121 | MP0001730_embryonic_growth_arrest | 0.75057753 |
| 122 | MP0005451_abnormal_body_composition | 0.74800132 |
| 123 | MP0005670_abnormal_white_adipose | 0.73798540 |
| 124 | MP0009053_abnormal_anal_canal | 0.73602342 |
| 125 | MP0002080_prenatal_lethality | 0.73235409 |
| 126 | MP0004233_abnormal_muscle_weight | 0.72987564 |
| 127 | MP0000516_abnormal_urinary_system | 0.72930892 |
| 128 | MP0000350_abnormal_cell_proliferation | 0.71967647 |
| 129 | MP0005083_abnormal_biliary_tract | 0.71958023 |
| 130 | MP0010630_abnormal_cardiac_muscle | 0.71853850 |
| 131 | MP0000477_abnormal_intestine_morphology | 0.71572423 |
| 132 | MP0004264_abnormal_extraembryonic_tissu | 0.71015261 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.70554116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 4.08490069 |
| 2 | Recurrent bronchitis (HP:0002837) | 4.07786781 |
| 3 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.02359782 |
| 4 | Recurrent viral infections (HP:0004429) | 3.82437022 |
| 5 | B lymphocytopenia (HP:0010976) | 3.77385657 |
| 6 | Abnormality of B cell number (HP:0010975) | 3.77385657 |
| 7 | Agammaglobulinemia (HP:0004432) | 3.73813809 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 3.69713111 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 3.52128994 |
| 10 | Papilloma (HP:0012740) | 3.49405902 |
| 11 | Verrucae (HP:0200043) | 3.49405902 |
| 12 | Chronic otitis media (HP:0000389) | 3.46387742 |
| 13 | Cellulitis (HP:0100658) | 3.35872332 |
| 14 | T lymphocytopenia (HP:0005403) | 3.35411215 |
| 15 | Colitis (HP:0002583) | 3.31078592 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.26377342 |
| 17 | Septate vagina (HP:0001153) | 3.21722329 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.19565679 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.14332270 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.14093741 |
| 21 | Thyroiditis (HP:0100646) | 3.12687807 |
| 22 | Combined immunodeficiency (HP:0005387) | 3.05318304 |
| 23 | Abnormality of the fingertips (HP:0001211) | 2.98155064 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.96618748 |
| 25 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.87774191 |
| 26 | Progressive external ophthalmoplegia (HP:0000590) | 2.86925684 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86463480 |
| 28 | Severe combined immunodeficiency (HP:0004430) | 2.86231443 |
| 29 | Hypoplasia of the thymus (HP:0000778) | 2.85042283 |
| 30 | Meningitis (HP:0001287) | 2.84816667 |
| 31 | Sparse lateral eyebrow (HP:0005338) | 2.81808040 |
| 32 | Pustule (HP:0200039) | 2.81707442 |
| 33 | Deep venous thrombosis (HP:0002625) | 2.75552652 |
| 34 | Severe visual impairment (HP:0001141) | 2.73511104 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.71255670 |
| 36 | Abnormality of T cells (HP:0002843) | 2.67776756 |
| 37 | Thrombocytosis (HP:0001894) | 2.65223361 |
| 38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65027252 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.63629724 |
| 40 | Hypertensive crisis (HP:0100735) | 2.62031090 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.59972177 |
| 42 | Bronchitis (HP:0012387) | 2.58526995 |
| 43 | IgM deficiency (HP:0002850) | 2.58074154 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.56716939 |
| 45 | Hyperacusis (HP:0010780) | 2.54107149 |
| 46 | Emphysema (HP:0002097) | 2.51526311 |
| 47 | Recurrent sinusitis (HP:0011108) | 2.50576652 |
| 48 | Truncus arteriosus (HP:0001660) | 2.48052232 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.47673265 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44730914 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.43977620 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.43954015 |
| 53 | Slow saccadic eye movements (HP:0000514) | 2.43616210 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.41783187 |
| 55 | Bowel incontinence (HP:0002607) | 2.40710817 |
| 56 | Myocardial infarction (HP:0001658) | 2.35573599 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35088267 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35088267 |
| 59 | Abnormal large intestine physiology (HP:0012700) | 2.30623981 |
| 60 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.29756023 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.29521758 |
| 62 | Lymphopenia (HP:0001888) | 2.29368892 |
| 63 | Recurrent otitis media (HP:0000403) | 2.29337921 |
| 64 | Squamous cell carcinoma (HP:0002860) | 2.26781228 |
| 65 | Lip pit (HP:0100267) | 2.26292348 |
| 66 | Eosinophilia (HP:0001880) | 2.23726290 |
| 67 | Long palpebral fissure (HP:0000637) | 2.22747057 |
| 68 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.22220922 |
| 69 | Increased IgE level (HP:0003212) | 2.21079929 |
| 70 | Deep palmar crease (HP:0006191) | 2.19078387 |
| 71 | Loss of speech (HP:0002371) | 2.18311033 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.17314060 |
| 73 | Broad face (HP:0000283) | 2.16637076 |
| 74 | Vasculitis (HP:0002633) | 2.16481086 |
| 75 | Broad distal phalanx of finger (HP:0009836) | 2.16250164 |
| 76 | Abnormality of the aortic arch (HP:0012303) | 2.15847660 |
| 77 | Mitral stenosis (HP:0001718) | 2.15719071 |
| 78 | Recurrent skin infections (HP:0001581) | 2.15664920 |
| 79 | Reticulocytosis (HP:0001923) | 2.15433088 |
| 80 | Breast hypoplasia (HP:0003187) | 2.14431555 |
| 81 | Abnormality of the columella (HP:0009929) | 2.12864103 |
| 82 | Periodontitis (HP:0000704) | 2.12340408 |
| 83 | Gastrointestinal stroma tumor (HP:0100723) | 2.11988997 |
| 84 | Easy fatigability (HP:0003388) | 2.10695329 |
| 85 | Granulocytopenia (HP:0001913) | 2.10181483 |
| 86 | Xanthomatosis (HP:0000991) | 2.10036018 |
| 87 | Hypoparathyroidism (HP:0000829) | 2.09302180 |
| 88 | Osteomyelitis (HP:0002754) | 2.05614620 |
| 89 | Abnormal platelet volume (HP:0011876) | 2.04645144 |
| 90 | Gingival bleeding (HP:0000225) | 2.04632682 |
| 91 | Obstructive sleep apnea (HP:0002870) | 2.03905460 |
| 92 | Chronic sinusitis (HP:0011109) | 2.03366339 |
| 93 | Seborrheic dermatitis (HP:0001051) | 2.00320612 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 2.00304331 |
| 95 | Myositis (HP:0100614) | 2.00180411 |
| 96 | Progressive muscle weakness (HP:0003323) | 2.00157814 |
| 97 | Orchitis (HP:0100796) | 1.99139774 |
| 98 | Hypochromic anemia (HP:0001931) | 1.98984661 |
| 99 | Sepsis (HP:0100806) | 1.98344730 |
| 100 | Skin ulcer (HP:0200042) | 1.97825052 |
| 101 | Hematochezia (HP:0002573) | 1.97495664 |
| 102 | Spontaneous hematomas (HP:0007420) | 1.96811193 |
| 103 | Abnormality of the thoracic spine (HP:0100711) | 1.96119121 |
| 104 | Poikiloderma (HP:0001029) | 1.95190372 |
| 105 | Basal cell carcinoma (HP:0002671) | 1.94717645 |
| 106 | Ulnar bowing (HP:0003031) | 1.94446536 |
| 107 | Epistaxis (HP:0000421) | 1.94357395 |
| 108 | Leukocytosis (HP:0001974) | 1.93313649 |
| 109 | Hyperthyroidism (HP:0000836) | 1.90960019 |
| 110 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90315408 |
| 111 | Malnutrition (HP:0004395) | 1.89583824 |
| 112 | Thin bony cortex (HP:0002753) | 1.89076312 |
| 113 | Abnormality of eosinophils (HP:0001879) | 1.88165140 |
| 114 | Intestinal fistula (HP:0100819) | 1.86677352 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.86454410 |
| 116 | Impulsivity (HP:0100710) | 1.84916062 |
| 117 | IgG deficiency (HP:0004315) | 1.84442922 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 1.84141481 |
| 119 | Optic neuritis (HP:0100653) | 1.84141481 |
| 120 | Arterial thrombosis (HP:0004420) | 1.84015631 |
| 121 | Lymphoma (HP:0002665) | 1.83816223 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 1.82577522 |
| 123 | Cholecystitis (HP:0001082) | 1.82577522 |
| 124 | Chest pain (HP:0100749) | 1.82503091 |
| 125 | Trismus (HP:0000211) | 1.80882796 |
| 126 | Polycythemia (HP:0001901) | 1.79097057 |
| 127 | Upper motor neuron abnormality (HP:0002127) | 1.78649851 |
| 128 | Long eyelashes (HP:0000527) | 1.77476811 |
| 129 | Encephalitis (HP:0002383) | 1.77468309 |
| 130 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.77372247 |
| 131 | Thoracic kyphosis (HP:0002942) | 1.76183278 |
| 132 | Increased mean platelet volume (HP:0011877) | 1.75489743 |
| 133 | Dysmetric saccades (HP:0000641) | 1.75277042 |
| 134 | Restrictive lung disease (HP:0002091) | 1.74813073 |
| 135 | Gingivitis (HP:0000230) | 1.73773876 |
| 136 | Stridor (HP:0010307) | 1.72837150 |
| 137 | Skin rash (HP:0000988) | 1.72538545 |
| 138 | Abnormality of the thymus (HP:0000777) | 1.72313999 |
| 139 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.70880058 |
| 140 | Personality changes (HP:0000751) | 1.69871927 |
| 141 | Entropion (HP:0000621) | 1.69468532 |
| 142 | Aortic aneurysm (HP:0004942) | 1.67170364 |
| 143 | Ureteral stenosis (HP:0000071) | 1.67138650 |
| 144 | Hyperlipoproteinemia (HP:0010980) | 1.66236308 |
| 145 | Unilateral renal agenesis (HP:0000122) | 1.66072741 |
| 146 | Distal upper limb amyotrophy (HP:0007149) | 1.65653469 |
| 147 | Upper limb amyotrophy (HP:0009129) | 1.65653469 |
| 148 | Spastic diplegia (HP:0001264) | 1.65429993 |
| 149 | Increased serum ferritin (HP:0003281) | 1.64431011 |
| 150 | Urethral obstruction (HP:0000796) | 1.64387488 |
| 151 | Bicuspid aortic valve (HP:0001647) | 1.64319370 |
| 152 | Heterotopia (HP:0002282) | 1.63995703 |
| 153 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.63836982 |
| 154 | Prolonged bleeding time (HP:0003010) | 1.63200340 |
| 155 | Flattened epiphyses (HP:0003071) | 1.63163315 |
| 156 | Dislocated radial head (HP:0003083) | 1.62995593 |
| 157 | Ureteral obstruction (HP:0006000) | 1.62710341 |
| 158 | Obstructive lung disease (HP:0006536) | 1.62531089 |
| 159 | Chronic obstructive pulmonary disease (HP:0006510) | 1.62531089 |
| 160 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.62080294 |
| 161 | Abnormality of reticulocytes (HP:0004312) | 1.61171605 |
| 162 | Neonatal hypoglycemia (HP:0001998) | 1.60984395 |
| 163 | Hand muscle atrophy (HP:0009130) | 1.58769597 |
| 164 | Glossoptosis (HP:0000162) | 1.58482859 |
| 165 | Persistence of primary teeth (HP:0006335) | 1.58273024 |
| 166 | Microcytic anemia (HP:0001935) | 1.57431518 |
| 167 | Selective tooth agenesis (HP:0001592) | 1.57062558 |
| 168 | Germ cell neoplasia (HP:0100728) | 1.56527013 |
| 169 | Patellar dislocation (HP:0002999) | 1.56397740 |
| 170 | Hypergonadotropic hypogonadism (HP:0000815) | 1.56205852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 3.96443600 |
| 2 | MAP4K1 | 3.75673682 |
| 3 | ERN1 | 3.43468789 |
| 4 | SMG1 | 3.30852311 |
| 5 | TRIB3 | 3.24028325 |
| 6 | IRAK3 | 3.01642266 |
| 7 | PKN2 | 2.96401122 |
| 8 | EEF2K | 2.94498391 |
| 9 | PRPF4B | 2.80089591 |
| 10 | STK10 | 2.42152903 |
| 11 | GRK6 | 2.35151024 |
| 12 | TYK2 | 2.10527879 |
| 13 | LRRK2 | 2.04825601 |
| 14 | FGFR4 | 1.92109379 |
| 15 | SIK1 | 1.86232092 |
| 16 | BLK | 1.81413520 |
| 17 | ZAP70 | 1.81048261 |
| 18 | BTK | 1.76517824 |
| 19 | CDK12 | 1.76515806 |
| 20 | FLT3 | 1.74985533 |
| 21 | RIPK4 | 1.68540212 |
| 22 | NME2 | 1.67097444 |
| 23 | CSF1R | 1.64450644 |
| 24 | TBK1 | 1.63603388 |
| 25 | TAOK3 | 1.49379497 |
| 26 | NEK2 | 1.48701009 |
| 27 | TTN | 1.48041281 |
| 28 | MAP3K13 | 1.47980265 |
| 29 | JAK3 | 1.44779762 |
| 30 | ITK | 1.37358778 |
| 31 | MAP2K3 | 1.34566401 |
| 32 | PIM2 | 1.30502614 |
| 33 | KIT | 1.25599386 |
| 34 | MAP3K7 | 1.22413227 |
| 35 | CSK | 1.21671662 |
| 36 | IKBKE | 1.20612763 |
| 37 | TAOK2 | 1.17993373 |
| 38 | MST1R | 1.17618795 |
| 39 | CAMK1D | 1.17095967 |
| 40 | CDK4 | 1.15007816 |
| 41 | SYK | 1.14992432 |
| 42 | PTK6 | 1.13596729 |
| 43 | TEC | 1.13001833 |
| 44 | JAK1 | 1.10967153 |
| 45 | BRD4 | 1.10603714 |
| 46 | HCK | 1.08326508 |
| 47 | KSR2 | 1.04396077 |
| 48 | EPHB1 | 1.03157955 |
| 49 | IRAK2 | 1.02071756 |
| 50 | MAP3K1 | 1.01169736 |
| 51 | SIK2 | 1.00802248 |
| 52 | AKT3 | 1.00758511 |
| 53 | KDR | 0.99502729 |
| 54 | MAPKAPK3 | 0.99421984 |
| 55 | PDPK1 | 0.99307306 |
| 56 | STK4 | 0.99265673 |
| 57 | TLK1 | 0.96384613 |
| 58 | DYRK1B | 0.95983341 |
| 59 | PIM1 | 0.95254981 |
| 60 | MAP2K2 | 0.93545424 |
| 61 | MAP3K8 | 0.93445502 |
| 62 | RPS6KB2 | 0.93022495 |
| 63 | MAPK11 | 0.91606688 |
| 64 | TESK1 | 0.91181976 |
| 65 | CDK7 | 0.90595342 |
| 66 | RPS6KC1 | 0.89734674 |
| 67 | RPS6KL1 | 0.89734674 |
| 68 | CAMK1G | 0.87163767 |
| 69 | LCK | 0.87111678 |
| 70 | TGFBR2 | 0.85702902 |
| 71 | CDK9 | 0.85697139 |
| 72 | TAOK1 | 0.83832882 |
| 73 | FGFR3 | 0.82926733 |
| 74 | CDK6 | 0.82609884 |
| 75 | RPS6KA2 | 0.80354034 |
| 76 | TESK2 | 0.80262139 |
| 77 | BRAF | 0.79596015 |
| 78 | CDC42BPA | 0.78330771 |
| 79 | RPS6KA6 | 0.77809959 |
| 80 | NLK | 0.77587963 |
| 81 | ICK | 0.77550927 |
| 82 | STK38 | 0.76969033 |
| 83 | MARK3 | 0.76868164 |
| 84 | MAP3K14 | 0.73687145 |
| 85 | SIK3 | 0.72922206 |
| 86 | IKBKB | 0.72890143 |
| 87 | IRAK4 | 0.72635910 |
| 88 | MTOR | 0.72179721 |
| 89 | SCYL2 | 0.70772175 |
| 90 | RPS6KA1 | 0.69432676 |
| 91 | CHEK2 | 0.68380732 |
| 92 | MOS | 0.67741243 |
| 93 | PDK4 | 0.67014663 |
| 94 | PDK3 | 0.67014663 |
| 95 | PRKD3 | 0.64938089 |
| 96 | JAK2 | 0.64440864 |
| 97 | MAP3K3 | 0.62869877 |
| 98 | EPHA2 | 0.62108829 |
| 99 | LYN | 0.61621536 |
| 100 | RPS6KA4 | 0.59131725 |
| 101 | RIPK1 | 0.58736982 |
| 102 | AURKA | 0.57108834 |
| 103 | PASK | 0.56815737 |
| 104 | CDK8 | 0.56415571 |
| 105 | TXK | 0.55943692 |
| 106 | DYRK3 | 0.55464870 |
| 107 | BCKDK | 0.53323100 |
| 108 | MAPK15 | 0.53091894 |
| 109 | HIPK2 | 0.51459038 |
| 110 | DDR2 | 0.51148931 |
| 111 | MAP3K11 | 0.50993272 |
| 112 | IRAK1 | 0.50267559 |
| 113 | CHUK | 0.50101735 |
| 114 | PLK4 | 0.48198631 |
| 115 | RAF1 | 0.48047586 |
| 116 | CDK2 | 0.44619079 |
| 117 | MATK | 0.43223454 |
| 118 | FES | 0.42863613 |
| 119 | CDC7 | 0.42551549 |
| 120 | PRKD2 | 0.42394998 |
| 121 | MAPK4 | 0.42156408 |
| 122 | MAP2K6 | 0.41832745 |
| 123 | ATR | 0.41793299 |
| 124 | FGFR2 | 0.41035990 |
| 125 | RET | 0.40955222 |
| 126 | MARK2 | 0.40181956 |
| 127 | PDGFRB | 0.39342373 |
| 128 | PRKCI | 0.38855456 |
| 129 | TNK2 | 0.38469000 |
| 130 | ZAK | 0.37955652 |
| 131 | MST4 | 0.37521376 |
| 132 | MAPK8 | 0.36607677 |
| 133 | PRKCQ | 0.36154905 |
| 134 | RPS6KA5 | 0.36096773 |
| 135 | PAK4 | 0.35988511 |
| 136 | PDK1 | 0.35435191 |
| 137 | PAK2 | 0.35333670 |
| 138 | CLK1 | 0.32842368 |
| 139 | CHEK1 | 0.32798499 |
| 140 | PDGFRA | 0.32286176 |
| 141 | PTK2 | 0.32000485 |
| 142 | PRKD1 | 0.31188330 |
| 143 | BMX | 0.31178423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.65052666 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.63557929 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08715385 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69442649 |
| 5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65898437 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61071388 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55486181 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.55428237 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54202328 |
| 10 | Lysine degradation_Homo sapiens_hsa00310 | 1.49807917 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.47564560 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46548407 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46531461 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46123352 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.45064976 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.44836365 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.43926340 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42602490 |
| 19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.38352587 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.37793711 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33914745 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.31240245 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28839448 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25024518 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24486421 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24307639 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23685164 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23034526 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22430919 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17133910 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.14962555 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.14188540 |
| 33 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13628080 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11026108 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.08957300 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08584724 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08264314 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.07522444 |
| 39 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07351370 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06417726 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06049871 |
| 42 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05091974 |
| 43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03459295 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.03366842 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.03060923 |
| 46 | Prostate cancer_Homo sapiens_hsa05215 | 1.01824423 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01709394 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01206790 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00684716 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00641020 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00057231 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.99858225 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99291011 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98470061 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97774268 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.96129196 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.95625513 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94512414 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93668538 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93514763 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93318018 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92006651 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91556377 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 0.91436316 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89727145 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.88979303 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88101920 |
| 68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88062560 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87455716 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.86938078 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86492479 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86025779 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85229215 |
| 74 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.84582736 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84461038 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83840014 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83190916 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82446283 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.82396656 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82387943 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81803107 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79210134 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77940247 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76746054 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75808035 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74990876 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73211893 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73131920 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73090811 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72750378 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72285196 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.72177258 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.71665732 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71639520 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70960544 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70765053 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70226933 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70187823 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69901335 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.69305778 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69110975 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67906457 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.67481729 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65675159 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65403730 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63742977 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63686069 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63248259 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.63182870 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62761685 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61332025 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60777476 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59705084 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59112686 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.58118457 |
| 116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57868194 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57184337 |
| 118 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56523623 |
| 119 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55449520 |
| 120 | Mismatch repair_Homo sapiens_hsa03430 | 0.54669175 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54078323 |
| 122 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53823254 |
| 123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.53585262 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.53389357 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52550657 |
| 126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51992936 |
| 127 | Spliceosome_Homo sapiens_hsa03040 | 0.51249847 |
| 128 | Cell cycle_Homo sapiens_hsa04110 | 0.51008635 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50731343 |
| 130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50302546 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49977086 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.49763033 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49736093 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47671116 |
| 135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47472787 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45493019 |

